693
Views
38
CrossRef citations to date
0
Altmetric
Review

Wnt signaling as potential therapeutic target in lung cancer

, , , , , & show all
Pages 999-1015 | Received 03 Oct 2015, Accepted 12 Feb 2016, Published online: 03 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Shan Lin, Yu Zhen, Yinghui Guan & Huanfa Yi. (2020) Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer. Cancer Management and Research 12, pages 4181-4191.
Read now
Lakshmanan Loganathan, Karthikeyan Muthusamy, John Marshal Jayaraj, Afrinrilwana Kajamaideen & Josephine Julia Balthasar. (2019) In silico insights on tankyrase protein: A potential target for colorectal cancer. Journal of Biomolecular Structure and Dynamics 37:14, pages 3637-3648.
Read now
Thorsten Braun & Claude Gardin. (2017) Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML). Expert Opinion on Investigational Drugs 26:7, pages 803-811.
Read now
Meng Lian, Qian Shi, Jugao Fang, Ling Feng, Hongzhi Ma, Haizhou Wang, Liang Zhang, Hong Wang, Zhihong Ma & Honggang Liu. (2017) In vivo gene expression profiling for chemosensitivity to docetaxel-cisplatin-5-FU (TPF) triplet regimen in laryngeal squamous cell carcinoma and the effect of TPF treatment on related gene expression in vitro. Acta Oto-Laryngologica 137:7, pages 765-772.
Read now
Jing Xue, Jiali Yang, Meihui Luo, William C. Cho & Xiaoming Liu. (2017) MicroRNA-targeted therapeutics for lung cancer treatment. Expert Opinion on Drug Discovery 12:2, pages 141-157.
Read now

Articles from other publishers (33)

Noriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, Ichidai Tanaka, Yosuke Miura, Seshiru Nakazawa, Yoichi Ohtaki, Reika Kawabata‐Iwakawa, Mitsuo Sato, Luc Girard, John D. Minna & Takeshi Hisada. (2023) The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β‐catenin signaling in lung cancer . Thoracic Cancer.
Crossref
Jiali Song, Longshan Li, Yang Fang, Yue Lin, Luojia Wu, Wei Wan, Gen Wei, Fuzhou Hua & Jun Ying. (2023) FOXN Transcription Factors: Regulation and Significant Role in Cancer. Molecular Cancer Therapeutics 22:9, pages 1028-1039.
Crossref
Shirong Li, Saiping Qi, Yanmeng Li, Chunpan Zhang, Lan Sun, Chunquan Liu & Haoyan Wang. (2023) MARVELD3 inhibits the epithelial‐mesenchymal transition and cell migration by suppressing the Wnt/β‐catenin signaling pathway in non–small cell lung cancer cells . Thoracic Cancer 14:12, pages 1045-1058.
Crossref
Yujia Zheng, Zheng Zhou, Ran Wei, Chu Xiao, Hao Zhang, Tao Fan, Bo Zheng, Chunxiang Li & Jie He. (2022) The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin. Journal of Translational Medicine 20:1.
Crossref
Yue Zheng, Laduona Wang, Limei Yin, Zhuoran Yao, Ruizhan Tong, Jianxin Xue & You Lu. (2022) Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. Frontiers in Oncology 12.
Crossref
Kang Liu, Li Cheng, Kun Zhu, Jinhu Wang & Qiang Shu. (2022) The cancer/testis antigen HORMAD1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer. Cell Death Discovery 8:1.
Crossref
Altan Kara, Aykut Özgür, Şaban Tekin & Yusuf Tutar. (2022) Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma. Anti-Cancer Agents in Medicinal Chemistry 22:3, pages 566-578.
Crossref
Xinxin Ke, Lulu He, Runan Wang, Jing Shen, Zhengyang Wang, Yifei Shen, Longjiang Fan, Jimin Shao & Hongyan Qi. (2021) miR-377-3p-Mediated EGR1 Downregulation Promotes B[a]P-Induced Lung Tumorigenesis by Wnt/Beta-Catenin Transduction. Frontiers in Oncology 11.
Crossref
Hongdan He, Xiaoni Shao, Yanan Li, Ribu Gihu, Haochen Xie, Junfu Zhou & Hengxiu Yan. (2021) Targeting Signaling Pathway Networks in Several Malignant Tumors: Progresses and Challenges. Frontiers in Pharmacology 12.
Crossref
Zhi-Han Li, Lei Lei, Liang-Ru Fei, Wen-Jing Huang, Yi-Wen Zheng, Mai-Qing Yang, Zhao Wang, Chen-Chen Liu & Hong-Tao Xu. (2020) TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial–mesenchymal transition. Journal of Molecular Histology 52:1, pages 11-20.
Crossref
Sidharth Mehan, Saloni Rahi, Shubham Upadhayay & Andleeb Khan. 2021. Polyphenols-based Nanotherapeutics for Cancer Management. Polyphenols-based Nanotherapeutics for Cancer Management 95 141 .
Marta Laganà, Cristina Gurizzan, Elisa Roca, Diego Cortinovis, Diego Signorelli, Filippo Pagani, Anna Bettini, Lucia Bonomi, Silvia Rinaldi, Rossana Berardi, Marco Filetti, Raffaele Giusti, Sara Pilotto, Michele Milella, Salvatore Intagliata, Alice Baggi, Alessio Cortellini, Hector Soto Parra, Matteo Brighenti, Fausto Petrelli, Chiara Bennati, Paolo Bidoli, Marina Chiara Garassino & Alfredo Berruti. (2020) High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases. Frontiers in Oncology 10.
Crossref
Sandrine Payan, Marc Montana, Christophe Curti, Laurent Greillier & Patrice Vanelle. (2020) Antibody–Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and Challenges. Targeted Oncology 15:4, pages 429-448.
Crossref
Xiu Lan, Weilong Lin, Yufen Xu, Yanyan Xu, Zhuqing Lv & Wenyu Chen. (2020) The detection and analysis of differential regulatory communities in lung cancer. Genomics 112:3, pages 2535-2540.
Crossref
JinHui Liu, YiCong Wan, Siyue Li, HuaiDe Qiu, Yi Jiang, Xiaoling Ma, ShuLin Zhou & WenJun Cheng. (2020) Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis. Cancer Medicine 9:10, pages 3522-3536.
Crossref
Judit Pako, Andras Bikov, Imre Barta, Hideyo Matsueda, Rita Puskas, Gabriella Galffy, Anna Kerpel-Fronius, Balazs Antus & Ildiko Horvath. (2018) Assessment of the circulating klotho protein in lung cancer patients. Pathology & Oncology Research 26:1, pages 233-238.
Crossref
Aimei Zou, Aibing Wu, Meihua Luo, Chengyu Zhou, Yan Lu & Xinfa Yu. (2019) SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway. Life Sciences 235, pages 116798.
Crossref
Zikuan Song, Haoyu Wang & Shuang Zhang. (2019) Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency. Biomedicine & Pharmacotherapy 118, pages 109336.
Crossref
Xia Han, Chunjuan Du, Yinghai Chen, Xiaofei Zhong, Feng Wang, Juan Wang, Changmin Liu, Mianli Li, Shaoshui Chen & Baosheng Li. (2019) Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer. Cancer Biomarkers 25:4, pages 325-332.
Crossref
Yu Wu, Ye Yang & Yin-Sheng Xian. (2019) HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma. Chemico-Biological Interactions 308, pages 357-363.
Crossref
Biao Gu, Jipeng Wang, Yaqi Song, Qi Wang & Qingquan Wu. (2018) microRNA‐383 regulates cell viability and apoptosis by mediating Wnt/β‐catenin signaling pathway in non–small cell lung cancer. Journal of Cellular Biochemistry 120:5, pages 7918-7926.
Crossref
Cong Liu, Wei Hu, Lin-Lin Li, Yu-Xuan Wang, Qun Zhou, Feng Zhang, Yi-Yan Song-Yang, Wei Zhu, Cheng-Chao Sun & De-Jia Li. (2018) Roles of miR-200 family members in lung cancer: more than tumor suppressors. Future Oncology 14:27, pages 2875-2886.
Crossref
Jiřina Procházková, Simona Strapáčová, Lucie Svržková, Zdeněk Andrysík, Martina Hýžďalová, Eva Hrubá, Kateřina Pěnčíková, Helena Líbalová, Jan Topinka, Jiří Kléma, Joaquín M. Espinosa, Jan Vondráček & Miroslav Machala. (2018) Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands. Toxicology Letters 292, pages 162-174.
Crossref
Xin-Hua Wang, Yan-Xiang Cui, Zhen-Min Wang & Jian Liu. (2018) Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway. Biochemical and Biophysical Research Communications 500:2, pages 229-235.
Crossref
Yanzhuo Luo, Zhaobo Xuan, Xiaofeng Zhu, Peng Zhan & Zhou Wang. (2018) Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma. Molecular Medicine Reports.
Crossref
Aymeric Monteillier, Pierre-Marie Allard, Katia Gindro, Jean-Luc Wolfender & Muriel Cuendet. (2018) Lung Cancer Chemopreventive Activity of Patulin Isolated from Penicillium vulpinum. Molecules 23:3, pages 636.
Crossref
William C.S. Cho. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology 129 136.e2 .
Shucai Yang, Yi Liu, Ming-Yue Li, Calvin S. H. Ng, Sheng-li Yang, Shanshan Wang, Chang Zou, Yujuan Dong, Jing Du, Xiang Long, Li-Zhong Liu, Innes Y. P. Wan, Tony Mok, Malcolm J. Underwood & George G. Chen. (2017) FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Molecular Cancer 16:1.
Crossref
Fanping Wang, Wenjun Wang, Junpeng Li, Jingjing Zhang, Xia Wang & Mingyong Wang. (2017) Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling. Oncology Letters.
Crossref
Xiong Jin, Xun Jin & Hyunggee Kim. (2017) Cancer stem cells and differentiation therapy. Tumor Biology 39:10, pages 101042831772993.
Crossref
Junquan Zeng, Xing Liu, Xiaofei Li, Yongliang Zheng, Bin Liu & Youzhang Xiao. (2017) Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling. Molecules 22:6, pages 862.
Crossref
Chuanpit Ninsontia, Preeyaporn Plaimee Phiboonchaiyanan, Chayanin Kiratipaiboon & Pithi Chanvorachote. (2017) Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated β-catenin degradation. American Journal of Physiology-Cell Physiology 312:4, pages C487-C499.
Crossref
Juan Sebastian Yakisich, Neelam Azad, Vivek Kaushik, George A O’Doherty & Anand Krishnan V Iyer. (2017) Nigericin decreases the viability of multidrug-resistant cancer cells and lung tumorspheres and potentiates the effects of cardiac glycosides. Tumor Biology 39:3, pages 101042831769431.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.